Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06352788 · ClinicalTrials.gov registry record · NA
From Opinion to Evidence: Multi-site Evaluation of Custom Dynamic Orthosis Best Practices
A NA study of Foot Injury, sponsored by Jason Wilken.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 5
- Study locations
NCT06352788 is a NA study of Foot Injury that is actively recruiting participants, run by Jason Wilken. The registered enrollment target is 35 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT06352788, a NA study of Foot Injury, is actively recruiting participants, sponsored by Jason Wilken.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is designed to support evidence-based practice and optimal care by evaluating how different configurations of two types of carbon fiber custom dynamic orthoses (CDOs) influences outcomes following traumatic lower extremity injury.
Conditions Studied
Interventions
- DEVICE Modular Carbon Fiber Custom Dynamic Orthosis (CDO)
- DEVICE Mono Carbon Fiber Custom Dynamic Orthosis (CDO)
Study Locations (5)
Minnesota
- Minneapolis VA Health Care System - Motion Analysis Laboratory - Minneapolis
- Mayo Clinic - Motion Analysis Lab - Rochester
California
- Naval Medical Center San Diego - Clinical Biomechanics Laboratory - San Diego
Iowa
- University of Iowa - Iowa City
Tennessee
- Vanderbilt University - Zelik Lab For Biomechanics & Assistive Technology - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2024-07-02 |
| Est. Completion | 2028-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06352788
The ClinicalTrials.gov registry entry for NCT06352788 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jason Wilken, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Foot Injury appearing as the primary indexed condition, and to 2 interventions - of which Modular Carbon Fiber Custom Dynamic Orthosis (CDO) is the first listed.
NCT06352788 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Minnesota, California, Iowa.
Frequently Asked Questions
What is clinical trial NCT06352788 about?
NCT06352788 is a clinical study titled "From Opinion to Evidence: Multi-site Evaluation of Custom Dynamic Orthosis Best Practices". This study is designed to support evidence-based practice and optimal care by evaluating how different configurations of two types of carbon fiber custom dynamic orthoses (CDOs) influences outcomes following traumatic lower extremity injury.
What is the current status of trial NCT06352788?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2024-07-02. Estimated completion is 2028-09-01.
What conditions does trial NCT06352788 study?
This clinical trial studies the following conditions: Foot Injury.
What interventions are being tested in trial NCT06352788?
The interventions under investigation include: Modular Carbon Fiber Custom Dynamic Orthosis (CDO) (DEVICE), Mono Carbon Fiber Custom Dynamic Orthosis (CDO) (DEVICE).
Who is sponsoring clinical trial NCT06352788?
This trial is sponsored by Jason Wilken, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06352788 being conducted?
This trial has 5 study locations across California, Iowa, Minnesota, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Foot Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.